Non brain penetrant A2A inhibitors and methods for use in the treatment of cancers
US11427594B2 · kind B2 · utility
0Cited by
0References
2Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Sep 26, 2019 |
| Grant date | Aug 30, 2022 |
| Priority date | — |
| Expiry date | Sep 26, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to compounds of Formula (I) or pharmaceutically acceptable salts thereof. The invention further relates to the use of the compounds of Formula (I) as A2A inhibitors. The invention also relates to the use of the compounds of Formula (I) for the treatment and/or prevention of proliferative disorders, including cancers.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.